Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future.

Keywords

Authors and Affiliations

Greifswald, Germany

Katharina Kichko

About the author

Katharina Kichko has written this book within her PhD program at the University of Greifswald.

Bibliographic Information

Book Title: Personalized Medicine as Innovation
Book Subtitle: What Can Germany Learn from the USA
Authors: Katharina Kichko
Series Title: Gesundheitsmanagement und Gesundheitsökonomik
DOI: https://doi.org/10.1007/978-3-658-27843-4
Publisher: Springer Gabler Wiesbaden
eBook Packages: Economics and Finance, Economics and Finance (R0)
Copyright Information: Springer Fachmedien Wiesbaden GmbH, part of Springer Nature 2019
Softcover ISBN: 978-3-658-27842-7Published: 26 September 2019
eBook ISBN: 978-3-658-27843-4Published: 21 September 2019
Series ISSN: 2523-7667
Series E-ISSN: 2523-7675
Edition Number: 1
Number of Pages: XXV, 354
Number of Illustrations: 29 b/w illustrations
Topics: Health Economics, Public Health, Innovation/Technology Management

Publish with us

Policies and ethics

Authors:

Sections

Buy it now

Buying options

Other ways to access

Table of contents (8 chapters)

Front Matter

Back Matter

About this book